Belvedere Trading
VERA icon

Belvedere Trading’s Vera Therapeutics VERA Stock Holding History

Belvedere Trading’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,700
Closed -$158K – 1141
2025
Q2 		$158K Buy
+6,700
New +$151K ﹤0.01% 463
2024
Q3 		– Sell
-7,200
Closed -$260K – 948
2024
Q2 		$260K Sell
7,200
-4,800
-40% -$190K ﹤0.01% 303
2024
Q1 		$517K Buy
+12,000
New +$428K ﹤0.01% 152

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Belvedere Trading's VERA Position: Q3 2025 in Review

Belvedere Trading sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 6,817 shares — an estimated $161K sold.

Belvedere Trading first reported a position in VERA in Q1 2024 and held it in 3 quarters. The position peaked at $191K in Q2 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Belvedere Trading reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Belvedere Trading sold 6,817 Vera Therapeutics shares in Q3 2025, an estimated $161K.
  • Belvedere Trading first reported a position in Vera Therapeutics in Q1 2024 and held it in 3 quarters.
  • Belvedere Trading's Vera Therapeutics position peaked at $191K in Q2 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Belvedere Trading's 13F filing for Q3 2025, filed 27 Oct 2025.